(Q35555511)

English

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

scientific article published on 14 October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

8 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Wolbink GJ

1

1 reference

Europe PubMed Central

8 August 2017

Voskuyl AE

2

1 reference

Europe PubMed Central

8 August 2017

Lems WF

3

1 reference

Europe PubMed Central

8 August 2017

de Groot E

4

1 reference

Europe PubMed Central

8 August 2017

Nurmohamed MT

5

1 reference

Europe PubMed Central

8 August 2017

Tak PP

6

1 reference

Europe PubMed Central

8 August 2017

Dijkmans BA

7

1 reference

Europe PubMed Central

8 August 2017

Aarden L

8

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

14 October 2004

1 reference

Europe PubMed Central

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

8 August 2017

64

1 reference

Europe PubMed Central

8 August 2017

5

1 reference

Europe PubMed Central

8 August 2017

704-707

1 reference

Europe PubMed Central

8 August 2017

Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755482

12 July 2018

Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755482

12 July 2018

Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755482

12 July 2018

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755482

12 July 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755482

12 July 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755482

7 December 2018

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15485995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of infliximab in academic rheumatology practice: an audit of early clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/15485995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15485995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2004.030452

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35555511&oldid=1525269200"